The assay that is being referred to here is called PubChem BioAssay. Its specific purpose is to use a thermal shift assay technique to identify whether a compound can bind to Keap1 protein's Kelch domain. The measurements are taken in a biochemical system using RT-PCR, and the name of the assay is 2119-02_Inhibitor_Dose_CherryPick_Activity. It is categorized as a confirmatory type of assay and is designed to target a single protein directly. The assay category for this testing process is considered as confirmatory, meaning that it is intended to verify previous findings. Moreover, the organism used in the assay is Homo sapiens, which indicates that it was conducted on human cells or tissues. Lastly, the type description of the assay is classified as functional, which shows that it is designed to determine the biological activity of a compound on the Keap1 protein's Kelch domain. Does this molecule show efficacy in this assay?